Home PsychoGenics

PsychoGenics

In operation
Donation/ Crowdfunding
Novel Drug Developer
Basic
Enterprise Profile

Basic Information

PsychoGenics is a biotechnology company focused on providing preclinical testing and research services for drug development. The company is dedicated to developing novel drugs for Huntington's disease, autism spectrum disorders, schizophrenia, depression, post-traumatic stress disorder (PTSD), Alzheimer's disease, Parkinson's disease, epilepsy, and more. Its drug discovery platforms, SmartCube, NeuroCube, and PhenoCube, are utilized by major pharmaceutical companies to develop innovative treatments.
PsychoGenics, lnc.
NewJersey,United States of America
51~100 people
January 01, 1999
info@psychogenics.com

Enterprise Profile

Industrial Sector
New Drug Development Drug Trial CRO
Technology
Biotechnology
Concept
Disease Treatment Depression Autism Epilepsy
Application Scenarios
AI+Pharmaceuticals